Market Overview

How To Approach Q4 Earnings: The Global Perspective

How To Approach Q4 Earnings: The Global Perspective

Even as the 2019 market attempts to shake off last year’s volatility, the incoming earnings season stands to disrupt traders attempts to restore normalcy. Earnings tend to be a trailing indicator, and reflect a company’s health and financial strategy anywhere from 3-6 month prior. If you’ve been paying attention, a lot happened in the last six months of 2018.

By taking a look at company financial data provided by stock research platform Finscreener — and contextualizing a few of the major unresolved economic questions from last year — a picture emerges of what factors are driving buying into the Q4 2018 postmortem.

The Global Perspective

It’s difficult to assess anything about the market without first reckoning with the ongoing issues regarding international trade and growth. Fears of a gradually slowing global economy started emerging mid-2018, alongside U.S. tariffs on goods from Canada, Mexico, the EU and, of course, China.

More recent concerns about anemic oil and commodity prices and rapidly contracting productivity in China have only added to the uncertainty. Recall, January’s batch of reports are coming on the tail of what turned out to be a devastating announcement from Apple Inc. (NASDAQ: AAPL) about the sluggishness of its emerging market sales, particularly in China.

What It Means For Earnings

These lingering events, as well as the prospect of a widely forecasted slowdown in the U.S. economy, are among the biggest macro considerations the market is carrying into the reporting season. One useful tool for getting an idea of a company's ability to weather the fallout of events like this is debt to capital ratios against its valuation and cash flow statistics.

By using Finscreener’s earnings calendar to first sort companies scheduled to report this month, then screening for those with a long term debt to capital ratio below 0.4, an interesting picture emerges of January’s first batch of reports. Keep in mind that this survey is limited to mega-cap (>$200 billion) companies on the S&P 500.


As you might expect, safety names like UnitedHealth Group Inc. (NYSE: UNH) Procter & Gamble Co. (NYSE: PG) and Johnson & Johnson (NYSE: JNJ) make appearances. However, more interesting are names with greater international exposure like Intel Corporation (NASDAQ: INTC), Microsoft Corporation (NASDAQ: MSFT) and Pfizer Inc. (NYSE: PFE), which are all set to report at the end of the month.

Keying in on Pfizer first, its strong performance in the past month seemingly runs counter to the company’s focus on continuing to invest its second largest market in China, which the company’s new CEO singled out as a priority upon beginning his tenure. Its average leverage statistics and relatively low valuation make its popularity a little less surprising.


Should the Jan. 29th report reflect more evidence of a slowing Chinese economy, expect investors to hit the stock hard. However, Pfizer’s overall financial health will likely carry it past any headwinds that might appear in its quarterly report.

Turning to the two tech concerns, given the trouble with Apple and the ongoing U.S. tariff on semiconductor components Microsoft (reporting Jan. 30) and Intel (reporting Jan. 24) might have more persistent troubles crop up on their financials this time around.

Relative to its price, Microsoft’s financials are uniformly low, which says a lot even as the stock is about 10 percent below its 52-week high. What’s more informative is Microsoft’s low cash flow statistics, which are even lower than those of the heavily leveraged Apple.


Alternatively, Intel, which is down more than 16 percent from its 2018 high, is in a much stronger valuation position to either weather a disappointing report or benefit from exceeding estimates.


Further benefiting Intel is its earnings track record, which reveals a long string of positive surprises and upward revisions.


It’s critical to remember that Intel, like Microsoft and Apple, has a big stake in China as both a supplier and buyer of their products, so a disappointing report is possible on all fronts.

Given the state of the market heading into this season, traders would benefit from researching the full financial picture of a company or industry to anticipate any surprises before they happen.

Posted-In: FinscreenerEarnings Global Markets Trading Ideas General Best of Benzinga


Related Articles (AAPL + INTC)

View Comments and Join the Discussion!

Veoneer's Active Safety Momentum Triggers Longbow Upgrade

Intermodal Rail Taking Growing Share Of Containers Out Of NY-NJ Ports